MAPT and Alzheimer disease: The CVN mouse model displays characteristics of human AD progression, including reactive astrocytes, neuroinflammation, amyloid deposition, phosphorylated tau protein, spatial memory impairments, and significant neuronal death in hippocampal, cortical, and thalamic regions [53–56].